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3The Danish approach to surveillance of antimicrobial resistance 
Integrated surveillance in the fight against antimicrobial resistance
Jørgen Schlundt
Director of the National Food Institute
Technical University of Denmark
Nils C. Strandberg Pedersen
President, CEO 
Statens Serum Institut
Antimicrobial agents are essential drugs for human and animal 
health. Infectious diseases that a person would typically die 
from before 1940 are now considered relatively harmless and 
receive standard treatment with a good recovery in most 
countries. 
However, we now run the risk that antimicrobial agents will 
become ineffective. The continuing emergence, development 
and spread of pathogenic organisms that are resistant to 
antimicrobial agents are a cause of increasing concern. 
Antimicrobial resistance is today a serious global public health 
issue that is impacted by use of antimicrobial agents for both 
humans and animals.
The Danish surveillance programme, DANMAP, has existed 
since 1995, covering the entire chain from farm to fork to 
sickbed. The DANMAP programme provides scientific data 
on the use of antimicrobial agents in animals and humans and 
monitors the occurrence of antimicrobial resistance in bacteria 
isolated from food animals, food and humans.
The success of the Danish approach is based on unique 
methods, where scientific data creates the basis for action and 
cross-sector collaboration between scientists and authorities. 
Other countries, including the USA, are now looking to the 
Danish experience, and world-leading scientists on food safety 
recommend adopting the Danish approach on surveillance of 
the consumption of antimicrobial agents and the occurrence of 
resistant bacteria in food animals, food and humans.
On the following pages, you can read about the Danish 
surveillance programme and the results we have achieved in 
our 15-year existence. However, we are continuously challenged 
by new emerging antimicrobial resistant bacteria that cross 
borders, and to prevent further spread of antimicrobial 
resistance global initiatives are needed.
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Facing the problem of antimicrobial resistance
Antimicrobial resistance is considered one of the major risks 
to human health. The use of antimicrobial agents is the main 
factor for selection and spread of antimicrobial resistance, 
although the relationship may be complex.
The resistance threat is a common problem of serious concern 
in industrialised as well as developing countries. There is now 
increasing awareness of the potential human health problems 
caused by antimicrobial resistance originating in food-
producing animals, as well as problems due to the transmission 
of resistant bacteria between patients. Resistant bacteria spread 
across borders via trade and travel and antimicrobial resistance 
is therefore a global problem.
Use of antimicrobial agents creating resistance
In order to limit the development and global emergence 
of resistant bacteria, it is important to monitor trends and 
The World Health Organization, WHO, has 
named resistance to antimicrobial agents 
one of the most significant threats to public 
health – a treat that can be combated by 
reducing the use of antimicrobial agents. 
If bacteria causing infectious diseases in 
humans can withstand treatment with 
antimicrobial agents, we are facing a dark 
future.
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DANMAP, the Danish Integrated Antimicrobial Resistance Monitoring and Research Programme, collects data from a 
variety of sources and is part of cross-sector collaboration between scientists and authorities where risk assessment and 
risk management are separated.
Organisation of DANMAP
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to identify the microbial and epidemiological risk factors 
contributing to the emergence and spread of antimicrobial 
resistance, as well as their interactions. Animal and human 
consumption of antimicrobial agents selects for antimicrobial 
resistant bacteria that can spread to humans through the food 
production chain. An integrated approach that takes this into 
account is therefore needed.
When bacteria are exposed to antimicrobial agents they can 
develop resistance either by mutation or by taking up resistance 
genes from other bacteria. Resistant bacteria from animals 
can be transferred to humans either through direct contact or 
consumption of meat or animal products. Resistant bacteria can 
also be transmitted between patients. Antimicrobial treatment 
failure may occur if the resistant bacteria are causing infections, 
or if resistance mechanisms are transferred to other pathogenic 
bacteria.
Global solutions needed
Resistant bacteria can spread through many routes – from 
animal to animal, between animals and humans, between 
humans and through the environment. The modern way of 
life also includes travelling around the world, importing food 
and livestock from other countries and continents – and the 
resistant bacteria are travelling along.
Therefore, antimicrobial resistance calls for global solutions.
Photo: Mikkel Adsbøl
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Occurrence of ESBL E. coli in broiler meat
During the past decade, the Danish surveillance programme, DANMAP, has reported a much higher level of resistance 
in bacteria like ESBL E. coli from imported meat than from domestically produced meat. This type of resistance seems 
to be related to food producing animals and may spread to humans via food.
DANMAP - Data for action
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The Danish approach – DANMAP
Since 1995, Denmark has maintained an integrated, cross-sector surveillance of the consumption 
of antimicrobial agents and occurrence of resistant bacteria in food animals, food and humans, 
named DANMAP, to safeguard human health.
In the 1990s, Danish scientists discovered a link between 
antimicrobial agents used as growth promoters in food 
animals, and resistance. They documented that the routine 
consumption of antimicrobial agents as growth promoters 
in animals lead to high occurrence of bacteria resistant to 
important antimicrobial agents used for human therapy in the 
animals. This was achieved by a systematic approach generating 
data determining the magnitude of current or potential future 
public health hazards from nonhuman use of antimicrobial 
agents. As a consequence, Danish authorities banned the use of 
the antimicrobial growth promoter avoparcin and established a 
national surveillance programme.
An increasing part of human infectious diseases originate from 
animals due to bacteria and viruses transferred from animals or 
food, for example Salmonellosis. Preventing such diseases thus 
requires cross-sector collaboration and surveillance.
National, cross-sector surveillance
The Danish Integrated Antimicrobial Resistance Monitoring 
and Research Programme, DANMAP, was established in 
1995 on the initiative of the Danish Ministry of Health and 
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the Danish Ministry of Food, Agriculture and Fisheries as a 
coordinated national surveillance and research programme 
for antimicrobial consumption and antimicrobial resistance in 
bacteria from food animals, food and humans. Denmark was 
the first country to establish such a systematic and continuous 
integrated monitoring programme. Similar surveillance 
programmes are now established in other countries as well.
To safeguard human health, DANMAP monitors the use of 
antimicrobial agents and the occurrence of antimicrobial 
resistance and studies the association between consumption of 
antimicrobial agents and resistance.
The programme participants are the National Food Institute 
and the National Veterinary Institute, both at Technical 
University of Denmark and Statens Serum Institut (SSI). 
The DANMAP programme is funded jointly by the Ministry 
of Health, the Ministry of Science, Innovation and Higher 
Education, and the Ministry of Food, Agriculture and Fisheries.
Part of the DANMAP data on veterinary use of antimicrobial 
agents derives from an IT monitoring programme called 
VetStat, which was initiated in 2000 by the Danish Government. 
VetStat collects data on prescribed medicine used in animals.
Separation of risk assessment and risk management
The strength of the integrated programme derives from 
collaboration between microbiologists, physicians, veterinarians 
and epidemiologists, offering a broad range of cross-sectorial 
expertise. The sampling involves, among others, veterinary 
practices, slaughterhouses, regional food control laboratories 
and hospitals. Furthermore, relevant stakeholders have access 
to all relevant data from animals, food, and humans. Photo: Mikkel Adsbøl
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Another characteristic of the Danish approach is that the 
surveillance and assessment of risks are separated from the 
handling of the potential risk. In Denmark, scientists are 
assessing the risk while the authorities, such as the Danish 
Veterinary and Food Administration and the Danish National 
Board of Health are conducting the risk management.
The objectives of DANMAP are:
•	 to monitor food animal and human consumption of antimicrobial agents
•	 to monitor the occurrence of antimicrobial resistance in bacteria isolated from food animals, food and humans
•	 to study associations between antimicrobial consumption and antimicrobial resistance
•	 to identify routes of transmission and areas for further research studies.
Since 1997, the results covering the three reservoirs food 
animals, food, and humans have been published in annual 
reports. The monitoring of antimicrobial resistance is based 
on three categories of bacteria: Human and animal pathogens, 
zoonotic bacteria, i.e. bacteria transferred from animals to 
humans, and indicator bacteria.
Human and animal pathogens are included because they cause 
infections and primarily reflect resistance caused by the use of 
antimicrobial agents in the respective reservoirs. 
Zoonotic bacteria are included because they can develop 
resistance in the animal reservoir, which may subsequently 
compromise treatment effect when causing infection in 
humans.
Indicator bacteria (Enterococci and E. coli) are included due to 
their ubiquitous nature in animals, food and humans, and their 
ability to readily develop or transfer antimicrobial resistance in 
response to selective pressure in both reservoirs.
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Consumption of antimicrobial agents in animals and humans
The first integrated surveillance report of consumption of antimicrobial agents in Denmark was published in 1996. In 1994, 
the consumption of antimicrobial growth promoters constituted more than half of the total antimicrobial consumption 
by animals in Denmark. The consumption of antimicrobial agents in animal production is approximately double the size 
of that of for humans. The total amount of antimicrobial agents used in animal production decreased in 2010, while the 
amount of prescribed human antimicrobial agents was the highest in the 15 years the Danish surveillance programme has 
existed. 
DANMAP - Data for action
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Results from 15 years of Danish surveillance
Results from the DANMAP programme 
have helped Danish authorities reduce 
antimicrobial resistance. In Denmark, based 
on solid scientific data from DANMAP, the 
spread of resistant bacteria in food animals, 
food and humans has been reduced by 
limiting the use of antimicrobial agents for 
animals and humans.
For several decades, antimicrobial agents were used as a feed 
additive for growth promotion in food animals and no one 
suspected it would create severe problems later on. In 1993, 
however, the first report of a nonhuman reservoir of bacteria 
resistant to the antimicrobial agent vancomycin, a vancomycin-
resistant Enterococcus, was published in the United Kingdom. 
In humans, Enterococci can cause serious hospital infections 
with a high mortality.
Reports from other European countries in 1994 indicated 
problems treating patients with infectious diseases due to 
resistant bacteria. By 1995, vancomycin-resistant Enterococci 
had been found in animals, humans and sewage in Germany. 
For the first time, scientists suspected resistance in human 
pathogens to originate from bacteria transferred from food 
animals.
In 1994, the consumption of antimicrobial growth promoters 
constituted more than half of the total antimicrobial con-
sumption by animals in Denmark, the total consumption at 
Photo: Mikkel Adsbøl
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Ban of growth promoters in general reduces use of antibiotics in animal production
Soon after the antimicrobial agents became commercially available, they were used in animal production, not only to treat 
animals with infections but also as growth promoters. Adding a low dose of antimicrobial agents to the feed made the 
animals grow faster. In 1995, Denmark banned the use of the antimicrobial growth promoter avoparcin. At the same time, 
another ban prohibited veterinarians from profiting from selling antibiotics. Five years after, all use of antimicrobial growth 
promoters was banned in Denmark.
Photo: Mikkel Adsbøl
DANMAP - Data for action
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that time being 206 tons. Growth promoters were used on 
virtually all broiler chicken and pig farms in Denmark, leading 
to a high level of resistance to bacteria from food animals. 
Scientific evidence led to ban of growth promoters
Danish scientists documented that routine consumption of 
antimicrobial growth promoters in animals led to resistant 
bacteria and problems in treating human infectious diseases. In 
1995, the Danish Minister of Agriculture and Fisheries imposed 
a national ban on the use of the antimicrobial growth promoter 
avoparcin. Despite the ban, the total use of growth promoters 
increased until the Danish pig and poultry producers 
voluntarily stopped using all antimicrobial growth promoters in 
finisher pigs and broiler chickens in 1998.
DANMAP measured and documented the effect of the 
avoparcin ban, and data showed that the ban had a substantial 
effect on lowering the occurrence of resistant Enterococci 
from broiler chickens. The data from DANMAP provided 
the evidence that led to the EU ban of avoparcin in 1997. As 
the first country, Denmark banned all antimicrobial growth 
promoters for animal feed additives in 2000 on a scientific basis. 
The final step towards terminating the use of antimicrobial 
agents for growth promotion in the entire EU was taken in 2002 
during the Danish EU presidency. The EU Council decided that 
all use of antimicrobial growth promoters should be terminated 
starting in 2006. 
Critically important antimicrobial agents in focus
Today, the focus has changed from antimicrobial growth 
promoters to antimicrobials critical for human therapy. In 
2007, World Health Organization identified a number of 
different types of antimicrobial agents critically important for 
treatment of serious infections in humans. Fluoroquinolones, 
cephalosporins and macrolides are among the most critically 
important antimicrobial agents. 
Results from DANMAP showed an increase of 230% in the 
consumption of fluoroquinolones in hospitals from 2001 
to 2007, resulting in increased resistance to E. coli from 
bloodstream infections.
In 2000, DANMAP reported an increase in macrolide 
resistance of Streptococcus pneumoniae in humans from 0% in 
1990 to 3.4% in 1999. Streptococcus pneumoniae is a pathogen 
causing pneumonia. This increase was related to a relatively 
high consumption of macrolides in human therapy. These 
results showed that even if the consumption of an antimicrobial 
agent generally is low, a small temporary rise in consumption 
can shift this balance in an unfavourable direction. Today, the 
level of resistance is approximately 4%, which is similar to the 
other Nordic countries, but much lower than that reported 
from other European countries.
During the 1990s, DANMAP reported an increase in the 
consumption of fluoroquinolones for animal production. In 
2002, Danish regulation restricted the use of fluoroquinolones 
in animal production, and consumption was reduced by 84% 
from 2001 to 2005. 
15The Danish approach to surveillance of antimicrobial resistance 
Farmers stopped using cephalosporins
Pig production accounts for about 80% of the total veterinary 
consumption of antimicrobial agents in Denmark, and the 
consumption of antimicrobial agents in pigs thus primarily 
determines the overall development in consumption. From 
2002 to 2004, antimicrobial use increased by 27% in pig 
production. To reduce the use of the critically important 
antimicrobial agents, fluoroquinolones and cephalosporins, 
new guidelines for pig production were introduced by 
the Danish Veterinary and Food Administration in 2005. 
DANMAP documented that the consumption continued to 
increase, also the use of cephalosporins.
 
In 2010, the guidelines were therefore supplemented by the so-
called ‘yellow card’. The farmers and the veterinarians that have 
the highest consumption of antimicrobial agents get a ‘yellow 
card’. The farmers and the veterinarians must together develop 
a plan for reducing the consumption of antimicrobial agents. 
DANMAP has documented that consumption of antimicrobials 
for pig production has been reduced significantly after the 
introduction of the ‘yellow card’.
In June 2010, the Danish Meat Association launched a 
voluntary programme discontinuing the use of cephalosporin 
for a two-year period in pigs. As a result, cephalosporin 
consumption saw a 50% reduction from 2009 to 2010.
Photo: Mikkel Adsbøl
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Resistance to avoparcin decreases after ban
In 1995, Denmark banned the use of the antimicrobial growth promoter avoparcin. Results from DANMAP show that 
the ban had a substantial effect on lowering the occurrence of resistance to avoparcin in broilers.
DANMAP - Data for action
17The Danish approach to surveillance of antimicrobial resistance 
Resistance to erythromycin follows the consumption
Macrolides are one group of antimicrobial agents that the World Health Organization has indicated as critically important 
antimicrobial agents for human therapy. The consumption of macrolides in pigs has decreased over the past 15 years, but 
it is still used. The resistance to one of the macrolides, erythromycin, has followed the decrease in the total consumption of 
macrolides, showing an association between consumption and resistance.
DANMAP - Data for action DANMAP - Data for action
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A new era in the fight against antimicrobial resistance
The fight against antimicrobial resistance is far from over. New multiresistant bacteria are 
spreading, threatening public health. Meanwhile, DANMAP is heading in new directions, testing new 
technological tools in the fight against antimicrobial resistance.
One of the fastest growing antimicrobial resistance problems in 
the world are the so-called ESBL-producing bacteria which are 
multiresistant not only to penicillins, but also to the critically 
important antimicrobial agents, cephalosporins. Different kinds 
of bacteria can be ESBL-producing, e.g. E. coli, Salmonella and 
Klebsiella. These bacteria can cause life-threatening infections 
in humans and treatment options against these infections are 
limited. Furthermore, infections with ESBL-producing bacteria 
often lead to prolonged hospitalisation and convalescence and 
are thus associated with significant human and economic costs.
ESBL E. coli bacteria from food animals and meat
Results from DANMAP show that nearly half of the broiler 
meat imported to Denmark in 2010 contained ESBL E. coli 
bacteria. In Danish broiler meat, the prevalence was five 
times lower. But surprisingly more than every fourth broiler 
contained ESBL at slaughter despite no usage of cephalosporins 
in the Danish broiler production for at least ten years. 
DANMAP scientists are currently studying the association. The 
higher prevalence in imported broiler meat is probably due to 
a higher consumption of antimicrobial agents in the broiler 
production in other countries. 
Also in public health care, an increase in incidences of ESBL 
E. coli bacteria in patients has been reported in DANMAP. 
The occurrence of the same type of ESBL in both animals and 
humans suggest that ESBL E. coli bacteria from food can cause 
infections in humans, but more research is needed to further 
investigate the human hazard in relation to the findings of 
ESBL-producing E. coli in meat and animals.
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Reduction in use of cephalosporins can reduce 
resistant bacteria in hospitals
In the recent years, DANMAP has reported an increasing 
prevalence of ESBL-producing Klebsiella bacteria that can 
lead to septicemia in humans. A recent initiative at Bispebjerg 
Hospital in Copenhagen shows that a 76% reduction in the 
consumption of cephalosporins resulted in a decrease of 
resistant Klebsiella bacteria from 43% to 16%.
Increasing number of MRSA cases 
MRSA, methicillin-resistant Staphylococcus aureus, is another 
emerging antimicrobial problem. Surveillance of MRSA in 
production animals, meat and humans has in the recent years 
been part of the DANMAP programme.
MRSA is a significant human pathogen that can cause a wide 
range of infections such as skin and soft tissue infections and 
bloodstream infections. MRSA is resistant to all beta-lactam 
antibiotics, including penicillins and cephalosporins. At 
hospitals, Staphylococcus aureus is the most common cause of 
post-surgery infections. As a response to the increasing number 
of cases of MRSA in humans, the Danish National Board of 
Health in 2006 issued new national MRSA guidelines focused 
on hospitals. 
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Farmers stopped using cephalosporins
Cephalosporins belong to the group of antimicrobial agents that the World Health Organization has indicated as critically 
important antimicrobial agents for human therapy. After an increase in the consumption of veterinary antimicrobial agents 
throughout the 2000s, the Danish authorities introduced the so-called “yellow card” to reduce the consumption in animal 
production. In mid-2010, the Danish farmers voluntarily stopped using cephalosporins in the pig production.
DANMAP - Data for action
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Resistance to fluoroquinolones in humans is increasing
DDD is the Defined Daily Dose, indicating the assumed average maintenance dose per day in adults.
DANMAP results showed an increase of 230% in the consumption of  fluoroquinolones from 2001 to 2007 in humans, 
resulting in increased resistance in E. coli from bloodstream infections. Fluoroquinolones belong to the group of 
antimicrobial agents that the World Health Organization has indicated as critically important antimicrobial agents for 
human therapy.
DANMAP - Data for action DANMAP - Data for action
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Increasing resistance in E. coli from human blood Increasing resistance in E. coli from human urine
Over the past decade, resistance to a variety of 
antimicrobial agents in E. coli has increased significantly 
in blood samples from patients in Danish hospitals. The 
level of resistance to third-generation cephalosporins in 
blood samples from patients reported in Denmark is now 
above the level in the other Nordic countries.
The past decade has seen an increase in the occurrence 
of resistance to ciprofloxacin and nalidixic acid in E. coli 
from urine samples from the Danish primary health care. 
Both ciprofloxacin and nalidixic acid belong to the group 
of antimicrobial agents called fluoroquinolones.
DANMAP - Data for actionDANMAP - Data for action
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Results from DANMAP showed that the number of new cases 
of humans with MRSA increased by 25% from 2009 to 2010 
– the highest level in 25 years. The increase in cases is seen 
especially outside hospitals, while the number of in-hospital 
cases remains low, indicating that the MRSA guidelines from 
2006 work. 
Many of the new cases of MRSA were seen in connection with 
foreign travel or family visits from abroad. The increasing use of 
antimicrobial agents in primarily the Danish healthcare sector 
has probably also contributed to the development. 
In recent years, the same types of MRSA are found in humans 
and in production animals, including pigs and cows. MRSA 
from swine is currently one of the major reservoirs for new 
MRSA cases in humans with an increase in the number of new 
cases from 40 in 2009 to 163 in 2011.
Swine MRSA originates from humans
New results from DANMAP scientists using a complete analysis 
of genetic material of bacteria have recently shed new light 
on the evolution of MRSA from swine, also known as MRSA-
CC398. The data show that MRSA-CC398 most probably 
originate from susceptible bacteria in humans. After the host 
jump it developed resistance. 
As a resistant bacterium, MRSA-CC398 has adapted to pigs and 
has had difficulties spreading to people who did not have direct 
contact with infected pigs. Since the original antibiotic-sensitive 
Staphylococcus originates from humans, it is possible that 
the newly emerging resistant bacteria will eventually adapt to 
people again, potentially leading to the bacteria spreading more 
easily between humans.
New technologies expecting to impact surveillance of 
antimicrobial resistance
Today, it can take days to determine the species, strain and 
resistance to antimicrobial agents of most pathogenic bacteria. 
However, using whole genome sequencing of bacterial genomes 
could potentially reduce this time to hours. This in turn opens 
up the possibility of doctors being able to treat patients with the 
right medicine while at the same time improving the chances of 
preventing infectious diseases from spreading.
DANMAP scientists have initiated validation projects that 
investigate the possibilities of using analysis of the complete 
genetic material of pathogenic bacteria in the surveillance of 
antimicrobial resistance, and these methods could become part 
of the surveillance programme in the future.
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Integrated global detection of infectious diseases
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In the future, complete analysis of genetic material of pathogenic bacteria in the surveillance of antimicrobial resistance 
might potentially be a fast, inexpensive, and simple global technology. Using genome sequencing can make it possible 
to identify pathogenic bacteria anywhere in the world and at the same time share and show the results online on, for 
example, web-based world maps. The technology is based on tools currently being developed at the Center for Genomic 
Epidemiology at the Technical University of Denmark.
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Participants in the DANMAP Programme
National Food Institute, Technical University of Denmark
www.food.dtu.dk
National Veterinary Institute, Technical University of Denmark
www.vet.dtu.dk
Statens Serum Institut
www.ssi.dk
www.danmap.org
The World Health Organization, WHO, has 
named resistance to antimicrobial agents 
one of the most significant threats to public 
health – a treat that can be combated by 
reducing the use of antimicrobial agents. 
If bacteria causing infectious diseases in 
humans can withstand treatment with 
antimicrobial agents, we are facing a dark 
future.
Since 1995, Denmark has maintained an 
integrated, cross-sector surveillance of the 
consumption of antimicrobial agents and 
occurrence of resistant bacteria in food 
animals, food and humans, named DANMAP, 
to safeguard human health.
Results from the DANMAP programme 
have helped Danish authorities reduce 
antimicrobial resistance. In Denmark, based 
on solid scientific data from DANMAP, the 
spread of resistant bacteria in animals, food 
and humans has been reduced by limiting 
the use of antimicrobial agents for animals 
and humans.
The fight against antimicrobial resistance is 
far from over. New multiresistant bacteria 
are spreading, threatening public health. 
Meanwhile, DANMAP is heading in new 
directions, testing new technological tools 
in the fight against antimicrobial resistance.
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